Skip to content
Eingeschlossene Patienten: 20.277 (Stand 1. März 2021) | |
Amgevita® (Adalimumab) | 110 |
Benepali® (Etanercept) | 767 |
Cimzia® (Certolizumab) | 946 |
Enbrel® (Etanercept) | 2865 |
Erelzi® (Etanercept) | 335 |
Flixabi® (Infliximab) | 9 |
Hulio® (Adalimumab) | 65 |
Humira® (Adalimumab) | 2903 |
Hyrimoz® (Adalimumab) | 85 |
Idacio® (Adalimumab) | 23 |
Imraldi® (Adalimumab) | 107 |
Inflectra™ (Infliximab) | 16 |
Jyseleca® (Filgotinib) | 6 |
Kevzara® (Sarilumab) | 154 |
Kineret® (Anakinra) | 89 |
MabThera® (Rituximab) | 1458 |
Nepexto® (Etanercept) | 8 |
Olumiant® (Baricitinib) | 432 |
Orencia® (Abatacept) | 862 |
Remicade® (Infliximab) | 762 |
Remsima® (Infliximab) | 11 |
Rinvoq® (Upadacitinib) | 124 |
Rixathon® (Rituximab) | 17 |
RoActemra® (Tocilizumab) | 1331 |
Simponi® (Golimumab) | 447 |
Xeljanz® (Tofacitinib) | 337 |
Zessly® (Infliximab) | 2 |
Kontrollen | 6006 |